| Announce Date | 11/20/2025 |
| EPS Normalized Actual | $1.62 (Miss by $-0.0099999999999998) |
| EPS GAAP Actual | $1.62 (Miss by $-0.0099999999999998) |
| Revenue Actual | $1.31841B |
| Revenue Surprise | Beat by $1318.41M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.61525 |
| EPS GAAP Estimate | $1.61525 |
| Revenue Estimate | $1.369058B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2027 | 2.57 | 29.21 | 2.55489 | 2.58511 | 1 |
| Sep 2026 | 5.2584 | 14.28 | 5.20457 | 5.31084 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.34 | -0.20713 | 1.31841B | 0.19% | -14.79M |
| FQ2 2025 (Jun 2025) | 1.87 | 0.385 | 1.3484B | 2.48% | 20.17M |
| FQ1 2025 (Mar 2025) | 1.7 | 0.1392 | 1.36179B | 0.99% | -4.88M |
| FQ4 2024 (Dec 2024) | 0.69 | 0.69 | 1.40267B | 5.39% | 1402.67M |
| FQ3 2024 (Sep 2024) | 1.2 | 1.2 | 1.31587B | 4.25% | 1315.87M |
| FQ2 2024 (Jun 2024) | 1.47 | 1.47 | 1.31493B | 9.6% | 1314.93M |
| FQ1 2024 (Mar 2024) | 1.31 | 1.31 | 1.34836B | 10.49% | 1348.36M |
| FQ4 2023 (Dec 2023) | 1.05 | 1.05 | 1.32704B | 5.86% | 1327.04M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.61525
Consensus Revenue Estimates
1.369058B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 1.76 | -- | 1.76 | 1.76 | 1 |
| FQ1 2027 (Mar 2027) | 2.02 | -- | 1.98189 | 2.05337 | 1 |
| FQ4 2026 (Oct 2026) | 1.5623 | -- | 1.53936 | 1.5841 | 0 |
| FQ3 2026 (Jul 2026) | 1.5202 | 11.85 | 1.49788 | 1.54142 | 0 |
| FQ2 2026 (Jun 2026) | 1.5901 | -17.6 | 1.57912 | 1.60419 | 0 |
| FQ1 2026 (Mar 2026) | 1.61525 | -5.25 | 1.6041 | 1.62956 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 1.44B | -- | 1.44B | 1.44B | 1 |
| FQ1 2027 (Mar 2027) | 1.46B | -- | 1.44B | 1.48B | 1 |
| FQ4 2026 (Oct 2026) | 1.89B | -- | 1.87B | 1.91B | 1 |
| FQ3 2026 (Jul 2026) | 1.82B | 27.75 | 1.8B | 1.84B | 1 |
| FQ2 2026 (Jun 2026) | 1.36B | 0.81 | 1.35B | 1.37B | 1 |
| FQ1 2026 (Mar 2026) | 1.37B | 0.53 | 1.36B | 1.38B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.54713 | 1.34 | -0.20713 | -15.46% |
| FQ2 2025 (Jun 2025) | 1.485 | 1.87 | 0.385 | 20.59% |
| FQ1 2025 (Mar 2025) | 1.5608 | 1.7 | 0.1392 | 8.19% |
| FQ4 2024 (Dec 2024) | 0.69 | 0.69 | 100% | |
| FQ3 2024 (Sep 2024) | 1.2 | 1.2 | 100% | |
| FQ2 2024 (Jun 2024) | 1.47 | 1.47 | 100% | |
| FQ1 2024 (Mar 2024) | 1.31 | 1.31 | 100% | |
| FQ4 2023 (Dec 2023) | 1.05 | 1.05 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.33B | $1.32B | $-14.79M | -1.12% |
| FQ2 2025 (Jun 2025) | $1.33B | $1.35B | $20.17M | 1.5% |
| FQ1 2025 (Mar 2025) | $1.37B | $1.36B | $-4.88M | -0.36% |
| FQ4 2024 (Dec 2024) | $0B | $1.4B | $1402.67M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.32B | $1315.87M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.31B | $1314.93M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.35B | $1348.36M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.33B | $1327.04M | 100% |